Starboard Value Issues Letter to Pfizer’s (PFE) Board of Directors
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 8/19/2026
- Wall St rises as yields ease, Moderna lifts healthcare stocks
- U.S. Treasury doubles buyback operation size for long-dated bonds
- Marvell shares jump after giving Google warrants amid custom chip deal
- Nvidia credit risk gauge hits new peak as SoftBank readies record bond issue
- Deutsche Bank calls Treasury buyback doubling similar to ’operation twist’
- Marvell issues Google warrant tied to custom chip deal
- Tech selloff weighs down Wall Street as bond yields climb
- FOMC minutes from July 28-29th meeting
- Lowe's Cos. (LOW) Tops Q2 EPS by 17c, Misses on Revenue; Offers Fy27 Guidance
- Nvidia or Sandisk? BofA reveals which stock is under-owned and which is crowded
Starboard Value Issues Letter to Pfizer’s Board of Directors
October 10, 2024 8:45 AM EDTNEW YORK--(BUSINESS WIRE)-- Starboard Value LP (together with its affiliates, Starboard or we), a significant shareholder of Pfizer Inc. (NYSE: PFE) (Pfizer or the Company), today issued the below letter to Companys Board of Directors.
***
October 10, 2024
Pfizer Inc.
66 Hudson Boulevard East
New York, New York
10001
Attn: Board of Directors
CC: Doug Lankler, General Counsel
Dear Members of the Board,
As you know, Starboard Value LP (together with its affiliates, Starboard or we) is a large investor in Pfizer Inc. (Pfizer or the... More
